Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

Epstein–Barr virus-associated diseases are important global health concerns. As a group I carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial- and lymphatic-originated tumors. Moreover, EBV plays an etiological and pathogenic role in a number of non-neoplastic diseases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ya, Xie, Longlong, Shi, Feng, Tang, Min, Li, Yueshuo, Hu, Jianmin, Zhao, Lin, Zhao, Luqing, Yu, Xinfang, Luo, Xiangjian, Liao, Weihua, Bode, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801793/
https://www.ncbi.nlm.nih.gov/pubmed/33436584
http://dx.doi.org/10.1038/s41392-020-00376-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801793/
https://www.ncbi.nlm.nih.gov/pubmed/33436584
http://dx.doi.org/10.1038/s41392-020-00376-4

Ejemplares similares